Amneal Pharmaceuticals, Inc. AMRX Specialty — Intellectual property legal development expenses

Other segment segments

Similar metrics at other companies

IONSPatent Expenses

$1.6M+20.8%

IDCCResearch and portfolio development

$55.84M+17.7%

TMOSpecialty Diagnostics — Research and development expenses

$44M-2.2%

CNASpecialty — Other expenses

$12M-20.0%

CHDSpecialty Products Division — Research And Development Expense

$800K+33.3%

ORISpecialty Insurance — Claims and claim adjustment expenses attributable to insured events of prior years

$610.9M+19.6%

Questions, answered.

What is Amneal Pharmaceuticals, Inc.'s specialty — intellectual property legal development expenses?

Amneal Pharmaceuticals, Inc. (AMRX) reported specialty — intellectual property legal development expenses of $49K in Q1 2026.

How has Amneal Pharmaceuticals, Inc.'s specialty — intellectual property legal development expenses changed year-over-year?

Amneal Pharmaceuticals, Inc.'s specialty — intellectual property legal development expenses decreased by 9.3% year-over-year, from $54K to $49K.

What is the long-term trend for Amneal Pharmaceuticals, Inc.'s specialty — intellectual property legal development expenses?

Over 3 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s specialty — intellectual property legal development expenses has grown at a 16.4% compound annual growth rate (CAGR), from $154K to $243K.

What does specialty — intellectual property legal development expenses mean?

Costs incurred to secure, maintain, and defend patents and other intellectual property rights associated with the specialty segment's product portfolio. These expenses are essential for protecting market exclusivity and preventing generic competition for branded assets.